News & Events about Spectrum Pharmaceuticals Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, NATI, SPPI SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, NATI, SPPI PR Newswire NEW YORK, May 2, 2023 NEW YORK, May 2, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following...
NEW YORK, April 29, 2023 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of HOTH with Algorithm Sciences, Inc., whereby HOTH shareholders are expected to own approximately ...
Moore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law Firm Moore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law Firm PR Newswire NEW YORK, April 28, 2023 NEW YORK, April 28, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities...
NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)s...
JMP Securities lowered shares of Spectrum Pharmaceuticals (NASDAQ:SPPI Get Rating) from an outperform rating to a market perform rating in a report issued on Wednesday morning, The Fly reports. SPPI has been the topic of several other reports. HC Wainwright reaffirmed a buy rating and set a $4.00 ...